Stock RCUS ARCUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector ratings Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 20:24:01 11/09/2024 BST 		5-day change 1st Jan Change
16.94 USD +1.56% Intraday chart for Arcus Biosciences, Inc. +3.62% -11.47%
09-04 Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 04:50 PM
08-27 Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital MT
Main competitors
Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Composite Fundamentals Composite Valuation Composite Consensus Composite Momentum Composite Visibility Investor Rating ESG Refinitiv Capi. ($)
ARCUS BIOSCIENCES, INC. Stock Arcus Biosciences, Inc.
 -
D+
1.53B
LONZA GROUP AG Stock Lonza Group AG
A
46.68B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
B
42.88B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 -
B
32.89B
MODERNA, INC. Stock Moderna, Inc.
 -
B-
30.47B
CELLTRION, INC. Stock Celltrion, Inc.
C
30.1B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
B-
23.23B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
B+
15.24B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
B+
11.7B
QIAGEN N.V. Stock Qiagen N.V.
A
10.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
C+
10.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
C+
9.81B
REVOLUTION MEDICINES, INC. Stock Revolution Medicines, Inc.
 -
C-
6.95B
BACHEM HOLDING AG Stock Bachem Holding AG
B-
6.7B
IONIS PHARMACEUTICALS, INC. Stock Ionis Pharmaceuticals, Inc.
 -
B+
6.2B
HANGZHOU TIGERMED CONSULTING CO., LTD Stock Hangzhou Tigermed Consulting Co., Ltd
B+
5.48B
BLUEPRINT MEDICINES CORPORATION Stock Blueprint Medicines Corporation
B-
5.45B
PHARMARON BEIJING CO., LTD. Stock Pharmaron Beijing Co., Ltd.
B+
4.49B
Average
B
 16.67B
Weighted average by Cap.
B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. RCUS Stock
  4. Sector Arcus Biosciences, Inc.
  5. Sector ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition